Two more studies, one in Italy and the other out of the U.S., revealed that the controversial malaria drug, hydroxychloroquine, can reduce COVID deaths and even the risk of hospitalization.

The Blaze explains:

A study out of Italy found that HCQ reduces by 30% the risk of death for COVID-19 patients who are hospitalized. The result comes from an observational study of more than 3,400 COVID-19 patients in 33 Italian hospitals. […]

Another study, which looked at outpatient cases in New Jersey, found that a prescription of hydroxychloroquine reduced the risk of hospitalization by 47%. Because the study was conducted early in the pandemic, when mostly only symptomatic people were being tested, researchers believe their sample of more than 1,200 patients represents people with relatively more advanced cases of COVID-19.

READ: New studies show risk of COVID-19 hospitalization and death decreases with hydroxychloroquine use

Ever since U.S. President Donald Trump recommended the widely used malaria drug as a possible cure for COVID, there has been a backlash against its usage to fight the coronavirus. Many believe this backlash is often politically motivated.

Meanwhile, doctors reported that a breakout of Covid in one of India’s largest slums, Dharavi, was stopped by using a combination of hydroxychloroquine, vitamin D and Zinc. The slum was the backdrop for the hit movie Slumdog Millionaire. READ: This Indian slum contained a possible COVID-19 disaster with hydroxychloroquine

Nevertheless, in mid August, the FDA disallowed Henry Ford Health’s request to use hydroxychloroquine to treat COVID-19 patients. READ: FDA denies Henry Ford Health request to use hydroxychloroquine for COVID-19 patients